2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Fortress Biotech, Inc. | — | 3,860,467 | May 31, 2024 |
| Maraoui Claude | CEO | 1,250,000 | Aug 26, 2025 |
| De Paolantonio Ernest Robert | Officer | 259,907 | Mar 1, 2023 |
| Rosenwald Lindsay A Md | Director | 176,470 | Jul 10, 2024 |
| Smith Justin Adam | Director | 171,618 | Aug 7, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | Aug 26, 2025 | Maraoui Claude | CEO | Sell | 40.0 | -10,877 | -0.45% | ✗ | $81.3K |
| Aug 5, 2025 | Aug 7, 2025 | ROSENWALD LINDSAY A MD | Director | Neutral | 90.0 | +50,000 | 14.81% | ✗ | - |
| Aug 5, 2025 | Aug 7, 2025 | Smith Justin Adam | Director | Neutral | 90.0 | +20,000 | 13.19% | ✗ | - |
| Aug 5, 2025 | Aug 7, 2025 | Toledano Miranda Jayne | Director | Neutral | 90.0 | +20,000 | 22.57% | ✗ | - |
| Aug 5, 2025 | Aug 7, 2025 | Pearce Michael Cooper | Director | Neutral | 90.0 | +20,000 | 53.80% | ✗ | - |
| Aug 5, 2025 | Aug 7, 2025 | Herskowitz Neil | Director | Neutral | 90.0 | +20,000 | 22.57% | ✗ | - |
| Jun 25, 2025 | Jul 7, 2025 | Toledano Miranda Jayne | Director | Neutral | 85.0 | +7,173 | 8.81% | ✗ | - |
| Jun 25, 2025 | Jul 7, 2025 | ROSENWALD LINDSAY A MD | Director | Neutral | 77.5 | +7,173 | 2.17% | ✗ | - |
| Jun 25, 2025 | Jul 7, 2025 | Pearce Michael Cooper | Director | Neutral | 90.0 | +7,173 | 23.91% | ✗ | - |
| Jun 25, 2025 | Jul 7, 2025 | Smith Justin Adam | Director | Neutral | 82.5 | +7,173 | 4.97% | ✗ | - |
| Jun 25, 2025 | Jul 7, 2025 | Herskowitz Neil | Director | Neutral | 85.0 | +7,173 | 8.81% | ✗ | - |
| Jun 17, 2025 | Jun 20, 2025 | Alloush Ramsey | COO | Neutral | 85.0 | +46,863 | 9.28% | ✗ | - |
| Jun 17, 2025 | Jun 20, 2025 | Benesch Joseph | CFO | Neutral | 90.0 | +28,907 | 14.20% | ✗ | - |
| Jun 17, 2025 | Jun 20, 2025 | Maraoui Claude | CEO | Neutral | 77.5 | +49,277 | 2.10% | ✗ | - |
| May 2, 2025 | May 5, 2025 | Maraoui Claude | CEO | Sell | 51.3 | -4,834 | -0.21% | ✗ | $33.1K |
| May 2, 2025 | May 5, 2025 | Benesch Joseph | CFO | Sell | 46.3 | -2,409 | -1.17% | ✗ | $16.5K |
| May 2, 2025 | May 5, 2025 | Alloush Ramsey | COO | Sell | 48.8 | -2,857 | -0.56% | ✗ | $19.5K |
| Jan 3, 2024 | Apr 16, 2025 | Maraoui Claude | CEO | Neutral | 90.0 | +350,000 | 17.47% | ✗ | - |
| Jan 3, 2024 | Apr 16, 2025 | Benesch Joseph | CFO | Neutral | 90.0 | +160,000 | 348.08% | ✗ | - |
| Apr 4, 2025 | Alloush Ramsey | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 11, 2025 | Mar 11, 2025 | Maraoui Claude | CEO | Sell | 42.5 | -49,271 | -2.40% | ✗ | $246.8K |
| Mar 6, 2025 | Mar 10, 2025 | Maraoui Claude | CEO | Sell | 42.5 | -40,456 | -1.93% | ✗ | $203.5K |
| Mar 3, 2025 | Mar 5, 2025 | Maraoui Claude | CEO | Sell | 40.0 | -70,556 | -3.26% | ✗ | $360.8K |
| Feb 21, 2025 | Feb 24, 2025 | Benesch Joseph | CFO | Sell | 47.5 | -1,365 | -2.88% | ✗ | $7.1K |
| Aug 1, 2024 | Aug 1, 2024 | Benesch Joseph | CFO | Sell | 42.5 | -9,324 | -16.46% | ✗ | $51K |
| Jul 19, 2024 | Jul 23, 2024 | Pearce Michael Cooper | Director | Neutral | 90.0 | +30,000 | 100.00% | ✗ | - |
| Jul 23, 2024 | Jul 23, 2024 | Benesch Joseph | CFO | Sell | 46.3 | -4,055 | -6.68% | ✗ | $21.9K |
| Jul 19, 2024 | Pearce Michael Cooper | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 8, 2024 | Jul 10, 2024 | Smith Justin Adam | Director | Neutral | 85.0 | +9,728 | 7.22% | ✗ | - |
| Jul 8, 2024 | Jul 10, 2024 | Herskowitz Neil | Director | Neutral | 90.0 | +9,728 | 13.56% | ✗ | - |
| Jul 8, 2024 | Jul 10, 2024 | Toledano Miranda Jayne | Director | Neutral | 90.0 | +9,728 | 13.56% | ✗ | - |
| Jul 8, 2024 | Jul 10, 2024 | ROSENWALD LINDSAY A MD | Director | Neutral | 82.5 | +9,728 | 3.03% | ✗ | - |
| May 12, 2022 | May 31, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 27.5 | -250,000 | -6.08% | ✗ | - |
| May 31, 2024 | Fortress Biotech, Inc. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2024 | Mar 27, 2024 | ROSENWALD LINDSAY A MD | Director | Buy | 83.8 | +10,000 | 3.22% | ✗ | $30.4K |
| Mar 22, 2024 | Mar 25, 2024 | Maraoui Claude | CEO | Buy | 61.3 | +10,000 | 0.46% | ✗ | $34.8K |
| Mar 22, 2024 | Mar 25, 2024 | Smith Justin Adam | Director | Buy | 95.0 | +30,000 | 28.65% | ✗ | $104.1K |
| Mar 22, 2024 | Mar 25, 2024 | ROSENWALD LINDSAY A MD | Director | Buy | 90.0 | +20,000 | 6.88% | ✗ | $68K |
| Feb 22, 2024 | Feb 23, 2024 | Benesch Joseph | CFO | Sell | 47.5 | -2,450 | -3.88% | ✗ | $9.2K |
| Nov 7, 2023 | Dec 8, 2023 | Paley Jeffrey | Director | Sell | 27.5 | -2,500 | -2.14% | ✗ | $8.8K |
| Nov 28, 2023 | Nov 29, 2023 | Paley Jeffrey | Director | Sell | 27.5 | -1,745 | -2.41% | ✗ | $9.1K |
| Oct 13, 2023 | Oct 17, 2023 | Smith Justin Adam | Director | Buy | 95.0 | +33,000 | 46.01% | ✗ | $98.3K |
| Oct 6, 2023 | Oct 10, 2023 | Paley Jeffrey | Director | Buy | 91.3 | +15,000 | 26.10% | ✗ | $44.7K |
| Sep 21, 2023 | Sep 25, 2023 | Paley Jeffrey | Director | Buy | 95.0 | +30,000 | 109.20% | ✗ | $89.1K |
| Sep 6, 2023 | Sep 8, 2023 | Maraoui Claude | CEO | Buy | 82.5 | +26,044 | 1.22% | ✗ | $65.6K |
| Sep 6, 2023 | Sep 8, 2023 | ROSENWALD LINDSAY A MD | Director | Buy | 95.0 | +100,000 | 52.43% | ✗ | $223K |
| Jul 21, 2023 | Jul 25, 2023 | Herskowitz Neil | Director | Neutral | 90.0 | +27,472 | 62.09% | ✗ | - |
| Jul 21, 2023 | Jul 25, 2023 | Paley Jeffrey | Director | Neutral | 90.0 | +27,472 | 62.09% | ✗ | - |
| Jul 21, 2023 | Jul 25, 2023 | Smith Justin Adam | Director | Neutral | 90.0 | +27,472 | 62.09% | ✗ | - |
| Jul 21, 2023 | Jul 25, 2023 | Toledano Miranda Jayne | Director | Neutral | 90.0 | +27,472 | 62.09% | ✗ | - |
| Jul 24, 2023 | Jul 25, 2023 | Maraoui Claude | CEO | Sell | 48.8 | -20,767 | -0.97% | ✗ | $36.5K |
| Jul 24, 2023 | Jul 25, 2023 | Benesch Joseph | Officer | Sell | 47.5 | -4,072 | -6.06% | ✗ | $7.2K |
| May 16, 2023 | May 18, 2023 | Maraoui Claude | CEO | Sell | 42.5 | -44,377 | -2.02% | ✗ | $57.7K |
| Oct 4, 2022 | Mar 1, 2023 | De Paolantonio Ernest Robert | Officer | Sell | 46.3 | -10,093 | -3.74% | ✗ | $24.3K |
| Feb 22, 2023 | Feb 23, 2023 | Benesch Joseph | CFO | Sell | 47.5 | -2,768 | -3.95% | ✗ | $5.5K |
| Jan 31, 2023 | Benesch Joseph | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 4, 2022 | Oct 6, 2022 | De Paolantonio Ernest Robert | CFO | Buy | 83.8 | +10,093 | 4.04% | ✗ | $24.3K |
| Jul 21, 2022 | Jul 25, 2022 | ROSENWALD LINDSAY A MD | Director | Neutral | 85.0 | +14,245 | 8.07% | ✗ | - |
| Jul 21, 2022 | Jul 25, 2022 | Smith Justin Adam | Director | Neutral | 90.0 | +14,245 | 47.48% | ✗ | - |
| Jul 21, 2022 | Jul 25, 2022 | Paley Jeffrey | Director | Neutral | 90.0 | +14,245 | 47.48% | ✗ | - |
| Jul 21, 2022 | Jul 25, 2022 | Herskowitz Neil | Director | Neutral | 90.0 | +14,245 | 47.48% | ✗ | - |
| Jul 21, 2022 | Jul 25, 2022 | Toledano Miranda Jayne | Director | Neutral | 90.0 | +14,245 | 47.48% | ✗ | - |
| Jul 21, 2022 | Jul 25, 2022 | Maraoui Claude | CEO | Neutral | 90.0 | +300,000 | 15.85% | ✗ | - |
| Jul 21, 2022 | Jul 25, 2022 | De Paolantonio Ernest Robert | CFO | Neutral | 90.0 | +150,000 | 125.00% | ✗ | - |
| Jul 25, 2022 | ROSENWALD LINDSAY A MD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 14, 2022 | Apr 4, 2022 | Herskowitz Neil | Director | Neutral | 90.0 | +30,000 | 100.00% | ✗ | - |
| Jan 14, 2022 | Apr 4, 2022 | Toledano Miranda Jayne | Director | Neutral | 90.0 | +30,000 | 100.00% | ✗ | - |
| Jan 14, 2022 | Apr 4, 2022 | Paley Jeffrey | Director | Neutral | 90.0 | +30,000 | 100.00% | ✗ | - |
| Jan 14, 2022 | Apr 4, 2022 | Smith Justin Adam | Director | Neutral | 90.0 | +30,000 | 100.00% | ✗ | - |
| Jan 14, 2022 | Apr 4, 2022 | De Paolantonio Ernest Robert | CFO | Neutral | 90.0 | +120,000 | 100.00% | ✗ | - |
| Apr 4, 2022 | Maraoui Claude | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 26, 2021 | Herskowitz Neil | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 26, 2021 | Toledano Miranda Jayne | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 26, 2021 | Smith Justin Adam | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 26, 2021 | Paley Jeffrey | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 26, 2021 | De Paolantonio Ernest Robert | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 26, 2021 | Maraoui Claude | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |